Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet Effect”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Post-approval studies (Phase 4)UnknownNCT01567774
What this trial is testing

Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Not applicableEnded earlyNCT03247972
What this trial is testing

Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Inova Health Care Services 30
Early research (Phase 1)Study completedNCT01841515
What this trial is testing

Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug

Who this might be right for
BleedingTachycardiaDyspnea
University of Ulsan 25
Post-approval studies (Phase 4)Study completedNCT00565500
What this trial is testing

Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin

Who this might be right for
Ischemic Heart DiseaseOsteoarthritis
University of Chieti 24
Post-approval studies (Phase 4)Study completedNCT01523392
What this trial is testing

A Pharmacodynamic Study With Ticagrelor in African American Patients

Who this might be right for
Stable Coronary Artery Disease
AstraZeneca 50
Not applicableStudy completedNCT01273935
What this trial is testing

Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke

Who this might be right for
Test the Efficacy of Antiplatelet Regimes in Acute Stroke
Ruhr University of Bochum 400
Large-scale testing (Phase 3)UnknownNCT01660373
What this trial is testing

Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome

Who this might be right for
Non-ST Segment Elevation Acute Coronary Syndrome
Pusan National University Yangsan Hospital 100
Not applicableUnknownNCT03005704
What this trial is testing

Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets

Who this might be right for
TicagrelorAspirinPlatelet Dysfunction Due to Drugs+1 more
Hamilton Health Sciences Corporation 10
Post-approval studies (Phase 4)Study completedNCT00915733
What this trial is testing

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism

Who this might be right for
Myocardial Infarction
Gyeongsang National University Hospital 80
Early research (Phase 1)Study completedNCT02370680
What this trial is testing

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

Who this might be right for
Cardiovascular Disease
New Haven Pharmaceuticals, Inc. 41
Post-approval studies (Phase 4)Study completedNCT00882388
What this trial is testing

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Who this might be right for
Healthy
Seoul National University Hospital 40
Not applicableUnknownNCT02054988
What this trial is testing

"Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy"

Who this might be right for
CORONARY ARTERY DISEASE
University of Roma La Sapienza 240
Not applicableUnknownNCT04338919
What this trial is testing

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary Intervention
Fujian Medical University 2,020
Post-approval studies (Phase 4)Looking for participantsNCT06228456
What this trial is testing

Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery Disease
University of Florida 50
Large-scale testing (Phase 3)Study completedNCT01805596
What this trial is testing

Effect of Ticagrelor on Endothelial Function

Who this might be right for
Coronary Artery DiseaseEndothelial Function
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 45
Not applicableStudy completedNCT00474123
What this trial is testing

Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe

Who this might be right for
Stable Angina
University of Sao Paulo 78
Not applicableStudy completedNCT01777516
What this trial is testing

In Vitro Interaction Between Ticagrelor and Its Active Metabolite and Their Effects on Salicylic Acid

Who this might be right for
Cardiovascular Diseases
Asan Medical Center 24
Post-approval studies (Phase 4)Study completedNCT01962428
What this trial is testing

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Who this might be right for
Non ST Segment Elevation Acute Coronary Syndrome
General Hospital of Chinese Armed Police Forces 250
Not applicableUnknownNCT02808039
What this trial is testing

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

Who this might be right for
Dual Antiplatelet TherapyPlatelet Reactivity
Rabin Medical Center 60
Large-scale testing (Phase 3)Study completedNCT01991795
What this trial is testing

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 19,271
Next Page